Genetic Analyses of Proteolysis, Hemoglobin Binding, and Hemagglutination of Porphyromonas gingivalis
CONSTRUCTION OF MUTANTS WITH A COMBINATION OF rgpA, rgpB, kgp, AND hagA*

Yixin ShiDagger , Dinath B. RatnayakeDagger , Kuniaki Okamoto§, Naoko Abe§, Kenji Yamamoto§, and Koji NakayamaDagger

From the Departments of Dagger  Microbiology and § Pharmacology, Faculty of Dentistry, Kyushu University, Fukuoka 812-8582, Japan

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Porphyromonas gingivalis produces arginine-specific cysteine proteinase (Arg-gingipain, RGP) and lysine-specific cysteine proteinase (Lys-gingipain, KGP) in the extracellular and cell-associated forms. Two separate genes (rgpA and rgpB) and a single gene (kgp) have been found to encode RGP and KGP, respectively. We constructed rgpA rgpB kgp triple mutants by homologous recombination with cloned rgp and kgp DNA interrupted by drug resistance gene markers. The triple mutants showed no RGP or KGP activity in either cell extracts or culture supernatants. The culture supernatants of the triple mutants grown in a rich medium had no proteolytic activity toward bovine serum albumin or gelatin derived from human type I collagen. Moreover, the mutants did not grow in a defined medium containing bovine serum albumin as the sole carbon/energy source. These results indicate that the proteolytic activity of P. gingivalis toward bovine serum albumin and gelatin derived from human type I collagen appears to be attributable to RGP and KGP. The hemagglutinin gene hagA of P. gingivalis possesses the adhesin domain regions responsible for hemagglutination and hemoglobin binding that are also located in the C-terminal regions of rgpA and kgp. A rgpA kgp hagA triple mutant constructed in this study exhibited no hemagglutination using sheep erythrocytes or hemoglobin binding activity, as determined by a solid-phase binding assay with horseradish peroxidase-conjugated human hemoglobin, indicating that the adhesin domains seem to be particularly important for P. gingivalis cells to agglutinate erythrocytes and bind hemoglobin, leading to heme acquisition.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Porphyromonas gingivalis is a Gram-negative anaerobic bacterium that is implicated as an important etiological agent of adult periodontal disease (1). P. gingivalis is asaccharolytic and highly proteolytic. Proteinases with trypsin-like activity, which are major extracellular and cell-associated proteinases of P. gingivalis, are now found to consist of arginine-specific cysteine proteinase (Arg-gingipain, RGP)1 and lysine-specific cysteine proteinase (Lys-gingipain, KGP) (2). Molecular genetic analyses have revealed that RGP is encoded by the two genes rgpA (rgp-1, prpR1, and prtR) and rgpB (rgp-2, prR2, and prtRII) (3-6), and KGP is encoded by the single gene kgp (prtP and prtK) (7-11). In addition to rgp and kgp, several proteinase-encoding genes have been cloned and characterized (12-14). Because of asaccharolysis, P. gingivalis is totally dependent on amino acids and peptides for its growth. However, it has not yet been determined what proteinase(s) is actually responsible for the degradation of environmental proteins and the generation of amino acids and peptides as carbon/energy sources.

Nucleotide sequencing revealed that rgpA consists of three DNA regions: (i) an N-terminal propeptide, (ii) a proteinase domain, and (iii) a C-terminal adhesin domain region (15). rgpB shares a high similarity in the N-terminal propeptide and proteinase domain with rgpA, and, importantly, the proteinase domains of the two genes are almost identical (4). Most of the C-terminal adhesin domain region is absent in rgpB (4). On the other hand, kgp has the same gene structure (an N-terminal propeptide, a proteinase domain, and a C-terminal adhesin region) as rgpA (7). Although the proteinase domains of kgp and rgpA are divergent, their C-terminal adhesin domain regions are very similar to each other (7). In addition to rgpA and kgp, part of the C-terminal adhesin domain region is also encoded by hagA and tla of P. gingivalis (16, 17). The C-terminal adhesin domain region of rgpA consists of four domains (HGP44, HGP15, HGP17, and HGP27) (15). One of the domain proteins, HGP15, was found to have the ability to bind hemoglobin by surface plasmon resonance detection using a recombinant HGP15 protein, and we proposed to designate this protein "hemoglobin receptor (HbR) domain protein" (18). The three other non-HbR domains (HGP44, HGP17, and HGP27) have a 49-amino acid-long sequence in common (15). At least two of the non-HbR domain proteins (HGP44 and HGP17) seem to be involved in hemagglutination of P. gingivalis, as suggested by the finding that monoclonal antibodies inhibiting hemagglutination recognize a particular amino acid sequence within the domain proteins (19-22).

Construction and analysis of a rgpA rgpB double mutant and a kgp mutant revealed that rgpA and rgpB are responsible for hemagglutination, the disruption of the bactericidal function of leukocytes, and the maturation of several P. gingivalis surface proteins such as fimbrilin (3, 23, 24), whereas kgp contributes to heme accumulation on the cell surface, resulting in colonial black pigmentation on blood agar plates (11). Although rgp and kgp seem to play different roles in cell metabolism, functional complementation between rgp and kgp may occur, judging from the structural similarity. To further elucidate the roles of these genes, we constructed rgpA rgpB kgp and rgpA kgp hagA triple mutants and examined them for proteolysis, hemoglobin binding, and hemagglutination.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Media and Conditions for Cell Growth-- P. gingivalis cells were grown anaerobically (10% CO2, 10% H2, and 80% N2) in enriched brain heart infusion (BHI) broth (3) and on enriched tryptic soy agar (3). For blood agar plates, defibrinated laked sheep blood was added to enriched tryptic soy agar at 5%. As a defined minimal medium, we used alpha -ketoglutarate/bovine serum albumin (alpha -KG/BSA) medium for the growth of P. gingivalis (25). To make trypsin-pretreated alpha -KG/BSA medium, trypsin was added to alpha -KG/BSA medium at a concentration of 50 µg/ml and incubated at 37 °C for 4 h. For selection and maintenance of the antibiotic-resistant strains, antibiotics were added to the medium at the following concentrations: ampicillin, 50 µg/ml; chloramphenicol (Cm), 20 µg/ml; erythromycin (Em), 10 µg/ml; and tetracycline (Tc), 0.7 µg/ml.

Construction of Plasmids and Bacterial Strains-- A promoterless cat DNA block (end-filled HindIII fragment; 0.75 kilobase pairs) of pCM7 (Amersham Pharmacia Biotech) was inserted into the end-filled EcoRI site within the kgp gene of pNKD (11), resulting in pKD362, which contained two tandem inserts of the cat block at the same orientation as kgp. A PstI fragment of pKD362 containing the kgp::cat operon fusion was introduced into P. gingivalis ATCC33277 and KDP112 (rgpA1::Tcr rgpB1::Emr) by electroporation to produce the Cm-resistant (Cmr) transformants KDP129 (kgp-2::Cmr) and KDP128 (rgpA1::Tcr rgpB1::Emr kgp-2::Cmr), respectively. An ermF ermAM DNA block (end-filled EcoRI-BamHI fragment) of pVA2198 (26) was inserted into the EcoRV site within the rgpA gene of P. g./pUC118 plasmid (27), resulting in pKD373. An EcoRI-BamHI fragment of pKD373 containing rgpA2::Emr was used for electrotransformation of ATCC33277 and KDP129 to yield KDP131 (rgpA2::Emr) and KDP134 (rgpA2::Emr kgp-2::Cmr), respectively. An EcoRI-SphI fragment of pKD314 (4) was ligated to the EcoRI-SphI fragment of pKD296 (4) to give rise to pKD317 containing the whole rgpB gene. A unique SmaI site within rgpB of pKD317 was converted to a BglII site using a BglII linker DNA to yield pKD376. A tetQ DNA block (2.7-kilobase pair BamHI-BglII fragment) of pKD375 that was derived from pMJF-3 (28) was inserted into the BglII site of pKD376, resulting in pKD377. A PstI fragment of pKD377 containing rgpB2::Tcr was introduced into ATCC33277, KDP129, and KDP134 to produce the Tcr transformants KDP132 (rgpB2::Tcr), KDP135 (rgpB2::Tcr kgp-2::Cmr), and KDP136 (rgpA2::Emr rgpB2::Tcr kgp-2::Cmr), respectively. A DNA region (936 base pairs) in the vicinity of the 5' end of the hagA gene was polymerase chain reaction-amplified from the chromosomal DNA of P. gingivalis ATCC33277 with two primers (5'-CGCTGCAGAAAGGTATTCGAACATC-3' and 5'-TCGGATCCGAGGGTTTCTTCCAGTA-3') and inserted into pMOSBlue plasmid by using a T-vector system (pMOSBlue T-vector kit; Amersham Pharmacia Biotech). A PstI-BamHI fragment of the resulting plasmid that contained the internal region of the hagA gene was then inserted into the PstI-BamHI region of pMJF-3, giving rise to pKD363. ATCC33277 and KDP134 were transformed to Tcr by electroporation with pKD363 circular plasmid DNA to yield KDP130 (hagA1::Tcr) and KDP137 (rgpA2::Emr kgp-2::Cmr hagA1::Tcr), respectively. Proper DNA replacement and integration in KDP136 and KDP137 were confirmed by Southern hybridization.

Enzymatic Assays-- Lys-X and Arg-X specific cysteine proteinase activities were determined by use of the synthetic substrates N-p-Tosyl-Gly-Pro-Lys-p-nitroanilide and N-alpha -benzoyl-DL-Arg-p-nitroanilide, respectively. In brief, various volumes of the cell lysates and supernatants of the culture were added to a reaction mixture (1 ml) containing 0.25 mM N-p-Tosyl-Gly-Pro-Lys-p-nitroanilide, 5 mM L-cysteine, and 20 mM phosphate buffer (pH 7.5) for KGP and a reaction mixture (1 ml) containing 0.5 mM N-alpha -benzoyl-DL-Arg-p-nitroanilide, 10 mM L-cysteine, 10 mM CaCl2, and 100 mM Tris-HCl (pH 8.0) for RGP. The reaction mixtures were incubated at 40 °C for KGP and at 30 °C for RGP. After the samples were added, absorbance was continuously measured at 405 nm on a spectrophotometer. Proteinase activities in cell extracts and culture supernatants were determined by the increase in absorbance per minute per milligram of protein and the increase in absorbance per minute per milliliter, respectively.

Hemagglutination Assay-- Forty-eight-h cultures of P. gingivalis strains in enriched BHI broth were centrifuged, washed with phosphate-buffered saline (PBS), and resuspended in PBS. The bacterial suspensions were then diluted in a twofold series with PBS. A 100-µl aliquot of each of the dilutions was mixed with an equal volume of sheep erythrocyte suspension (2.5% in PBS) and incubated in a round-bottomed microtiter plate at room temperature for 3 h.

Solid-phase Binding Assays-- Forty-eight-h cultures of P. gingivalis strains in enriched BHI broth were diluted in a twofold series with PBS, and a 10-µl aliquot of each of the dilutions was applied to nitrocellulose membranes and allowed to dry. The membranes were immersed in PBS containing 1% skim milk for 1 h at room temperature to block nonspecific protein binding. For hemoglobin binding activity, the membranes were then probed with horseradish peroxidase (HRP)-conjugated hemoglobin in PBS containing 0.5% BSA for 1 h at room temperature. HRP-conjugated hemoglobin was made according to the method of Kishore et al. (29). After three 10-min washes with PBS, peroxidase activity was detected (29). For antibody binding, rabbit anti-HbR antiserum (18) and mouse monoclonal antibody (mAb) 61BG1.3 for the detection of the non-HbR domain proteins (30) were used as the primary antibody, and HRP-conjugated anti-rabbit and anti-mouse IgGs were used as the secondary antibody, respectively.

Gel Electrophoresis and Immunoblot Analysis-- SDS-polyacrylamide gel electrophoresis was performed essentially according to the method of Laemmli (31). Before being solubilized in a sample buffer, P. gingivalis cells were treated with 10% trichloroacetic acid to inactivate endogenous proteinases. For immunoblotting, proteins on SDS gels were electrophoretically transferred to nitrocellulose membranes using a semi-dry blotting system (Amersham Pharmacia Biotech). The blotted membranes were immunostained with anti-HbR antiserum or mAb 61BG1.3, and signals were detected using an ECL detection system (Amersham Pharmacia Biotech).

Chemicals and Proteins-- N-p-Tosyl-Gly-Pro-Lys-p-nitroanilide, N-alpha -benzoyl-DL-Arg-p-nitroanilide, human hemoglobin, alpha -KG, BSA (type IV), and trypsin were purchased from Sigma. Gelatin derived from human type I collagen was obtained from Seikagaku Co. (Japan). HRP-conjugated anti-rabbit and anti-mouse IgGs were purchased from Santa Cruz Biotechnology.

Other Methods-- Electrotransformation and Southern blotting were done as described previously (3).

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Construction of the rgpA rgpB kgp and rgpA kgp hagA Triple Mutants-- We used the promoterless Cm acetyltransferase-encoding gene for the construction of a kgp insertional mutation because we had used the Emr gene (ermF) and the Tcr gene (tetQ) for the construction of rgpA and rgpB mutations. The kgp-2::Cmr mutant (KDP129) and the rgpA1::Tcr rgpB1::Emr kgp-2::Cmr mutant (KDP128) were obtained by the selection of Cmr transformants after the introduction of the kgp-2::Cmr DNA fragment to the wild type parent (ATCC33277) and the rgpA1::Tcr rgpB1::Emr mutant (KDP112), respectively, by electroporation. Southern analysis indicated the replacement of kgp with kgp-2::Cmr in KDP129 and KDP128 (Fig. 1). KDP129 showed no KGP activity, and KDP128 showed neither KGP nor RGP activity (Table I). In addition, KDP129 exhibited reduced colonial pigmentation on blood agar plates (Fig. 2), which was one of the characteristic features of a kgp mutant (11). Colonies of KDP128 showed less color on the blood agar plates than those of KDP129 (Fig. 2). KDP128 has integration-type mutations at the rgpA and rgpB loci. Because of the potential problem of instability in integration-type mutations, another rgpA rgpB kgp triple mutant (KDP136) was constructed from KDP129 by sequential replacement with linear DNA fragments containing rgpA2::Emr and rgpB2::Tcr mutations. The rgpA2::Emr kgp-2::Cmr hagA1::Tcr mutant (KDP137) was obtained by the introduction of pKD363 circular plasmid DNA containing the internal region of hagA into KDP134 (rgpA2::Emr kgp-2::Cmr). Determination of the proteolytic activities of the various mutants supported the fact that RGP is encoded by two separate genes, rgpA and rgpB, whereas KGP is encoded by a single gene, kgp (Table I).


View larger version (47K):
[in this window]
[in a new window]
 
Fig. 1.   Southern analysis of the kgp mutants. Chromosomal DNA of ATCC33277 (wild type) (lanes 1 and 5), KDP129 (kgp-2::Cmr) (lanes 2 and 6), KDP112 (rgpA rgpB) (lanes 3 and 7), and KDP128 (rgpA rgpB kgp-2::Cmr) (lanes 4 and 8) was digested with PstI (lanes 1-4) and BamHI (lanes 5-8). The digested DNA was subjected to agarose gel electrophoresis and Southern blot hybridization with a 1.2-kilobase pair HindIII fragment inside the N-terminal propeptide and catalytic domain-encoding region of kgp as a DNA probe.

                              
View this table:
[in this window]
[in a new window]
 
Table I
RGP and KGP activities of various P. gingivalis mutants
Forty-eight-h cultures of P. gingivalis strains in enriched BHI broth were centrifuged. The cell pellets were resuspended in PBS and disrupted by a supersonic vibrator. The cell extracts and culture supernatants were used for the determination of RGP and KGP activities. Data are the means ± standard errors of four independent experiments.


View larger version (149K):
[in this window]
[in a new window]
 
Fig. 2.   Colonial pigmentation. P. gingivalis ATCC33277 (wild type), KDP112 (rgpA rgpB), KDP128 (rgpA rgpB kgp), and KDP129 (kgp) were anaerobically grown on blood agar plates at 37 °C for 7 days.

Cell Growth in Enriched BHI Broth-- KDP112 (rgpA rgpB) and KDP128 (rgpA rgpB kgp) grew faster than ATCC33277 (wild type) and KDP129 (kgp) in enriched BHI broth (Fig. 3). Moreover, ATCC33277 and KDP129 showed a decrease in absorbance after 100 h of incubation, indicating cell lysis. Although the absorbance was also decreased in KDP128 and KDP112, the absorbance decreases of KDP128 and KDP112 were low and intermediate, respectively, compared with those of ATCC33277 and KDP129. These results indicate that the cell lysis seen after prolonged incubation appeared to be caused mainly by RGP and KGP.


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 3.   Growth of the rgp- and kgp-related mutants in enriched BHI broth. An overnight culture was diluted 20-fold with enriched BHI broth and incubated anaerobically at 37 °C. Growth was monitored by measuring the optical density at 540 nm. , ATCC33277; triangle , KDP129; open circle , KDP112; black-triangle, KDP128.

Degradation of Gelatin and BSA by Culture Supernatants of the rgp- and kgp-related Mutants-- The rgp- and kgp-related mutants were grown in enriched BHI broth. Supernatants of the cultures of a 3-day incubation were mixed with gelatin derived from human type I collagen or BSA. ATCC33277, KDP129, and KDP112 showed a complete degradation of gelatin, whereas KDP128 showed no degradation (Fig. 4a). KDP128 also showed no degradation of BSA (Fig. 4b). These results indicate that the extracellular proteolytic activity of P. gingivalis is totally attributable to RGP and KGP.


View larger version (54K):
[in this window]
[in a new window]
 
Fig. 4.   Digestion of gelatin and BSA by culture supernatants of the rgp- and kgp-related mutants. P. gingivalis cells were grown in enriched BHI broth for 3 days, and the culture supernatant was collected by centrifugation. Two µl of the culture supernatant were mixed with 2.5 µl of a protein solution (1 mg/ml) and 7.5 µl of a reaction buffer (80 mM Tris-HCl (pH 7.5), 0.32 M NaCl, 8 mM CaCl2, and 1.6 mM dithiothreitol) and incubated at 37 °C for 2 h. The reaction was terminated by adding 4 µl of Laemmli sample buffer and heating at 100 °C for 5 min. Samples were subjected to SDS-polyacrylamide gel electrophoresis. The protein bands on the gel were visualized by Coomassie Brilliant Blue R-250 staining. Molecular mass markers are as follows: phosphorylase b, 94 kDa; bovine serum albumin, 67 kDa; ovalbumin, 43 kDa; carbonic anhydrase b, 30 kDa; trypsin inhibitor, 20.1 kDa; and alpha -lactoalbumin, 14.4 kDa. a, gelatin derived from human type I collagen. b, gelatin derived from BSA. Lanes 1, no supernatants; lanes 2, KDP128; lanes 3, KDP112; lanes 4, KDP129; lanes 5, ATCC33277.

Cell Growth in alpha -KG/BSA Defined Medium-- The alpha -KG/BSA defined medium contains BSA as the sole carbon/energy source, and this medium supports the growth of wild type P. gingivalis cells (25). To determine whether P. gingivalis cells require RGP and KGP activities to grow in this medium, rgp- and kgp-related mutants were incubated in the medium. ATCC33277, KDP112, and KDP129 grew in this medium, whereas KDP128 did not grow (Fig. 5). KDP128 grew in the trypsin-predigested alpha -KG/BSA medium as well as ATCC33277. These results strongly indicate that RGP and KGP contribute to protein degradation, leading to the production of peptides utilizable as carbon/energy sources. KDP136 (rgpA rgpB kgp) and KDP133 (rgpA rgpB) showed the same results as KDP128 and KDP112, respectively, in cell growth in enriched BHI broth, degradation of gelatin and BSA by culture supernatants, and cell growth in the alpha -KG/BSA defined medium.


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 5.   Growth of the rgp- and kgp-related mutants in alpha -KG/BSA defined medium with or without trypsin predigestion. An overnight culture of P. gingivalis in enriched BHI broth was diluted 10-fold with alpha -KG/BSA medium (open circle , , triangle , and black-triangle) or trypsin-pretreated alpha -KG/BSA medium ( and black-square) and incubated anaerobically at 37 °C. Growth was monitored by measuring the optical density at 540 nm. open circle  and , ATCC33277; , KDP112; triangle , KDP129; black-triangle and black-square, KDP128.

Lack of Hemoglobin Binding Ability in the rgpA rgpB kgp and rgpA kgp hagA Triple Mutants-- P. gingivalis has the ability to bind hemoglobin (32-34). We found that the HbR protein of P. gingivalis was intragenically encoded by the rgpA, kgp, and hagA genes (18). In addition, another gene (tla) that was found to encode the HbR domain protein in the C-terminal region has recently been cloned (17). To determine which gene(s) is actually responsible for the production of the HbR protein, immunoblot analyses with anti-HbR antiserum were performed using cell lysates and intact cells of various mutants (Fig. 6, a and b). The wild type parent (ATCC33277), the rgpA rgpB mutants (KDP112 and KDP133), the kgp mutant (KDP129), and the rgpA kgp mutant (KDP134) exhibited the 19-kDa HbR protein in the lysates of cells grown in blood agar plates for 7 days, whereas the rgpA rgpB kgp mutants (KDP128 and KDP136) and the rgpA kgp hagA mutant (KDP137) produced no HbR protein in cell lysates. The intact cells of ATCC33277, KDP133, KDP129, and KDP134 reacted to the anti-HbR antiserum, whereas those of KDP136 and KDP137 showed no reaction with the antiserum. These results suggest that all three of the genes (rgpA, kgp, and hagA) contribute to the HbR expression of P. gingivalis. Then we determined the hemoglobin binding ability of the mutants (Fig. 7). The rgpA rgpB kgp mutants (KDP128 and KDP136) and the rgpA kgp hagA mutant (KDP137) showed no hemoglobin binding ability, whereas the cells of other strains (ATCC33277, KDP112, KDP129, KDP133, and KDP134) had the ability to bind hemoglobin, although the binding ability varied among the different strains. In addition, the fimA mutant KDP98 that is deficient in fimbriation (35) exhibited hemoglobin binding activity. These results indicate that hemoglobin binding activity appeared to be correlated to HbR expression. Because the HbR protein had hemoglobin binding activity in a cell-free system (18), it is plausible to consider that the hemoglobin binding ability of P. gingivalis is attributable to the HbR protein.


View larger version (36K):
[in this window]
[in a new window]
 
Fig. 6.   Expression of the HbR protein in the cell lysates and on the cell surfaces of the rgp- and kgp-related mutants. a, an immunoblot using anti-HbR antiserum. P. gingivalis cells were grown on blood agar plates for 7 days, harvested, and lysed with Laemmli sample buffer. Samples were subjected to SDS-polyacrylamide gel electrophoresis. Protein bands on the gel were transferred to a nitrocellulose membrane and immunoreacted with anti-HbR antiserum. Lane 1, ATCC33277; lane 2, KDP112; lane 3, KDP133; lane 4, KDP129; lane 5, KDP134; lane 6, KDP128; lane 7, KDP136; lane 8, KDP137; lane 9, KDP98. b, solid-phase binding assay with anti-HbR serum. P. gingivalis cells grown in enriched BHI broth for 48 h were washed with PBS and resuspended in the original volume of PBS. Ten µl of the suspension were applied to a nitrocellulose membrane and allowed to dry. The membrane was then subjected to the solid-phase binding assay using anti-HbR antiserum. Blots are as follows: 1, ATCC33277; 2, KDP136; 3, KDP137; 4, KDP129; 5, KDP133; and 6, KDP134.


View larger version (49K):
[in this window]
[in a new window]
 
Fig. 7.   Solid-phase hemoglobin binding assay. P. gingivalis cells grown in enriched BHI broth for 48 h were washed with PBS, resuspended in the original volume of PBS, and diluted in a 2-fold series with PBS. A 10-µl aliquot of each of the dilutions was applied to a nitrocellulose membrane and allowed to dry. The membrane was then subjected to the solid-phase binding assay using HRP-conjugated hemoglobin. Columns are as follows: 1, ATCC33277; 2, KDP112; 3, KDP133; 4, KDP129; 5, KDP134; 6, KDP128; 7, KDP136; 8, KDP137; and 9, KDP98.

No Hemagglutination of the rgpA rgpB kgp and rgpA kgp hagA Triple Mutants-- P. gingivalis has the ability to agglutinate erythrocytes, which is one of the significant features of this organism. Pike et al. (36) reported that the RGP/adhesin and KGP/adhesin complexes have hemagglutinating activity. A monoclonal antibody (mAb 61BG1.3) that inhibits the hemagglutination of P. gingivalis was found to recognize a peptide within the adhesin domain (HGP44 of rgpA) encoded by rgpA, kgp, and hagA (20, 21). To determine whether the rgp- and kgp-related mutants produce mAb 61BG1.3-reactive proteins, immunoblot analyses were performed using cell lysates and intact cells (Fig. 8, a and b). The wild type strain (ATCC33277), the rgpA rgpB mutant (KDP133), the kgp mutant (KDP129), and the rgpA kgp mutant (KDP134) produced immunoreactive proteins on the cell surfaces and in the cell lysates, whereas the rgpA rgpB kgp mutant (KDP136) and the rgpA kgp hagA mutant (KDP137) produced no reactive proteins on their cell surfaces. Interestingly, the rgpA kgp hagA mutant showed no reactive proteins in the cell lysate, whereas the rgpA rgpB kgp mutant produced immunoreactive proteins with molecular masses of more than 100 kDa that were probably derived from hagA. The rgpA rgpB kgp and rgpA kgp hagA mutants showed no hemagglutinating activity using sheep erythrocytes (Fig. 9). These results indicate that hemagglutination of P. gingivalis is caused by the rgpA-, kgp-, and hagA-encoding adhesin domains and that the expression of these adhesin domains on the cell surface is particularly important for hemagglutination.


View larger version (64K):
[in this window]
[in a new window]
 
Fig. 8.   Immunoblot and solid-phase analysis using mAb 61BG1.3. a, an immunoblot using mAb 61BG1.3. P. gingivalis cells were grown in enriched BHI broth for 48 h, harvested, and lysed with Laemmli sample buffer. Protein bands on the gel were transferred to a nitrocellulose membrane and immunoreacted with mAb 61BG1.3. Lane 1, ATCC33277; lane 2, KDP137; lane 3, KDP136; lane 4, KDP134; lane 5, KDP133; lane 6, KDP129. b, solid-phase binding assay with mAb 61BG1.3. Procedures were the same as those described in the legend to Fig. 6b, except that mAb 61BG1.3 was used. Blots are as follows: 1, ATCC33277; 2, KDP136; 3, KDP137; 4, KDP129; 5, KDP133; and 6, KDP134.


View larger version (111K):
[in this window]
[in a new window]
 
Fig. 9.   Hemagglutinating activity of the rgp- and kgp-related mutants. P. gingivalis cells were grown in enriched BHI broth, washed with PBS, and resuspended in PBS at an optical density at 540 nm of 0.4. The suspension and its dilutions in a 2-fold series were applied to the wells of a microtiter plate from left to right and mixed with sheep erythrocyte suspension. 1, ATCC33277; 2, KDP129; 3, KDP133; 4, KDP134; 5, KDP136; 6, KDP137.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

P. gingivalis cannot utilize carbohydrates as carbon/energy sources (37). Therefore, the microorganism has developed utilization of environmental amino acids and peptides by production of extracellular proteinases. In the gingiva, macromolecules such as serum albumin, immunoglobulins, hemoglobin, and various proteins of host tissues and secretions are target molecules for degradation to amino acids and peptides by the extracellular proteinases secreted from the organism. Although a number of extracellular and cell-associated proteinases have been found in P. gingivalis, it is still unclear which proteinase(s) is actually responsible for the production of utilizable amino acids and peptides. In this study, we found that the culture supernatants of the rgpA rgpB kgp triple mutants had no proteolytic activity to gelatin or BSA, indicating that the extracellular proteinase activity of P. gingivalis may be totally attributable to the three genes. The inability of the rgpA rgpB kgp mutants to grow in the alpha -KG/BSA defined medium supported this idea. Several proteinases other than RGP and KGP have been cloned and characterized (12-14). The results obtained here, however, suggest that these proteinases may not be located on the surface or secreted outside or may not be expressed under the culture conditions used in this study. We also found that the autolysis of P. gingivalis cells observed in prolonged cultures might be due mainly to extracellular and cell-associated RGP and KGP.

In our previous study (18), we found that the HbR domain protein that was intragenically encoded by rgpA, kgp, and hagA had the ability to bind hemoglobin. Immunoblot analysis using anti-HbR antiserum revealed that the rgpA kgp double mutant produced the 19-kDa HbR protein, whereas the rgpA kgp hagA triple mutant produced no HbR protein. The result indicates that hagA is responsible for HbR production as well as rgpA and kgp. Aduse-Opoku et al. (17) recently reported that the HbR domain region was also located within the tla gene cloned from the P. gingivalis W50 chromosome. However, they mentioned in the study that Northern analyses of mRNA had thus far failed to reveal the presence of a tla transcript in cells grown under any growth condition, indicating that there might be very little HbR production from the tla gene. A restriction map around the tla gene in ATCC33277 is different from that of W50 (17). An oligonucleotide probe recognizing the HbR region hybridized to three different restriction fragments of ATCC33277 chromosomal DNA, which were probably derived from the rgpA, kgp, and hagA loci.2 These results suggest another possibility: that the ATCC33277 chromosome may not possess the HbR domain region in the tla gene. Further investigation including the cloning and nucleotide sequencing of tla from ATCC33277 will be necessary for clarification of this issue. In the previous study (18), we also found that the rgpA rgpB mutant produced as much HbR as the wild type parent; however, the N terminus of the HbR from the rgpA rgpB mutant was Arg1155 (the residue number of the kgp primary gene product according to Okamoto et al.; Ref. 7) instead of Ala1156, indicating that cleavage at the N terminus might be done by KGP in the mutant. In this study, we found that the rgpA rgpB kgp triple mutant produced no 19-kDa HbR protein. Because the triple mutant produced mAb 61BG1.3-reactive proteins with high molecular masses, the hagA gene appears to be expressed in the triple mutant. Therefore, it is most likely that the processing and maturation of the HbR domain protein of hagA depend on the presence of both RGP and KGP activities. The finding that the hemoglobin binding activities of the various mutants were consistent with the presence or absence of HbR in the mutants indicates that the hemoglobin binding ability of P. gingivalis is caused mainly by HbR; however, Kuboniwa et al. (38) recently reported that the KGP proteinase domain itself has the ability to bind hemoglobin.

Hemagglutination is a distinctive characteristic of P. gingivalis that discriminates the microorganism from other asaccharolytic black-pigmented anaerobic organisms. This feature has been recognized to have taxonomic value, together with other important features such as the RGP and KGP activities, in distinguishing P. gingivalis from other Porphyromonas spp. Because P. gingivalis requires heme for growth, hemagglutination serves as the first step in heme acquisition from erythrocytes. We have previously found that the rgpA rgpB double (RGP-null) mutant showed decreased ability to agglutinate erythrocytes (3). Pike et al. (36) also reported that the high molecular mass RGP has hemagglutinin activity. These results suggest that the rgp genes are involved in hemagglutination. The hemagglutinin gene hagA of P. gingivalis that confers hemagglutination on Escherichia coli cells was found to possess the DNA region homologous to those of the C-terminal adhesin domains of rgpA and kgp (16). Moreover, mAb 61BG1.3, which reacts with an epitope within the adhesin domains, inhibits the hemagglutination of P. gingivalis (20, 21). No hemagglutination of the rgpA kgp hagA triple mutant observed in this study suggests that all three genes are responsible for hemagglutination. In addition to the adhesin domain proteins, RGP proteinase derived from rgpB is thought to be involved in the hemagglutinating activity because the rgpA rgpB kgp triple mutants showed less than 1.6% of the activity of the wild type parent, whereas the rgpA kgp double mutant showed 6.3% of the activity of the wild type parent. There are at least two possible explanations for the involvement of RGP in hemagglutination. One is that because maturation of the adhesin domains requires RGP activity, a complete defect of RGP would decrease hemagglutination if maturation of the adhesin domains from hagA is required for the agglutination. The other is that RGP-mediated modification of putative erythrocyte surface molecule(s) for binding to P. gingivalis cells would be necessary for hemagglutination.

Several other candidates such as fimbriae, HagB, and HagC have been proposed as a hemagglutinin of P. gingivalis (39-41). However, neither fimbriae nor anti-fimbria antibody inhibits hemagglutination (42). Purified fimbriae have also been shown to exhibit no hemagglutinating activity (43). In addition, we found that the rgpA kgp hagA mutant having no hemagglutinating activity expressed the fimA gene, resulting in fimbriation.3 Taken together, it is unlikely that fimbriae are responsible for hemagglutination of P. gingivalis, even if synthetic peptides derived from the amino acid sequence of fimbrilin possess hemagglutinating activity (44). The expression of hagB and hagC depends on the phase of bacterial growth and on the levels of hemin (45). Therefore, we cannot rule out the possibility that these genes contribute to the hemagglutination of P. gingivalis under conditions that differ from those used in this study. Although several problems concerning hemagglutination of P. gingivalis remain to be solved, it can be said that the non-HbR adhesin domain proteins encoded by rgpA, kgp, and hagA are the most important agglutinins for hemagglutination.

    ACKNOWLEDGEMENTS

We thank Dr. R. Gmur for kindly giving us monoclonal antibody 61BG1.3. General assistance by K. Sakai is acknowledged with appreciation.

    FOOTNOTES

* This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Science, Sports and Culture of Japan.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom correspondence should be addressed: Dept. of Microbiology, Faculty of Dentistry, Kyushu University, 3-1-1, Higashi-ku, Fukuoka, Fukuoka 812-8582, Japan. Tel.: 81-92-642-6332; Fax: 81-92-642-6263, E-mail: knak{at}dent.kyushu-u.ac.jp.

2 Y. Shi, D. B. Ratnayake, and K. Nakayama, unpublished observations.

3 Y. Shi, D. B. Ratnayake, A. Umeda, and K. Nakayama, unpublished observations.

    ABBREVIATIONS

The abbreviations used are: RGP, Arg-gingipain; KGP, Lys-gingipain; HbR, hemoglobin receptor; BHI, brain heart infusion; alpha -KG, alpha -ketoglutarate; BSA, bovine serum albumin; Cm, chloramphenicol; Cmr, chloramphenicol-resistant; Em, erythromycin; Emr, erythromycin-resistant; Tc, tetracycline; Tcr, tetracycline-resistant; PBS, phosphate-buffered saline; HRP, horseradish peroxidase; mAb, monoclonal antibody.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
  1. Haffajee, A. D., and Socransky, S. S. (1994) Periodontol. 2000 5, 78-111[Medline] [Order article via Infotrieve]
  2. Potempa, J., Pike, R., and Travis, J. (1995) Infect. Immun. 63, 1176-1182[Abstract]
  3. Nakayama, K., Kadowaki, T., Okamoto, K., and Yamamoto, K. (1995) J. Biol. Chem. 270, 23619-23626[Abstract/Free Full Text]
  4. Nakayama, K. (1997) Microbiol. Immunol. 41, 185-196[Medline] [Order article via Infotrieve]
  5. Mikolajczyk-Pawlinska, J., Kordula, T., Pavloff, N., Pemberton, P. A., Chen, W. C., Travis, J., and Potempa, J. (1998) Biol. Chem. Hoppe-Seyler 379, 205-211
  6. Aduse-Opoku, J., Rangarajan, M. J., Young, K. A., and Curtis, M. A. (1998) Infect. Immun. 66, 1594-1600[Abstract/Free Full Text]
  7. Okamoto, K., Kadowaki, T., Nakayama, K., and Yamamoto, K. (1996) J. Biochem. (Tokyo) 120, 398-406[Abstract]
  8. Pavloff, N., Pemberton, P. A., Potempa, J., Chen, W. C. A., Pike, R. N., Prochazka, V., Kiefer, M. C., Travis, J., and Barr, P. J. (1997) J. Biol. Chem. 272, 1595-1600[Abstract/Free Full Text]
  9. Barkocy-Gallagher, G. A., Han, A. N., Patti, J. M., Whitlock, J., Progulske-Fox, A., and Lantz, M. S. (1996) J. Bacteriol. 178, 2734-2741[Abstract]
  10. Slakeski, N., Bhogal, P. S., O'Brien-Simpson, N. M., and Reynolds, E. C. (1998) Microbiology 144, 1583-1592[Abstract]
  11. Okamoto, K., Nakayama, K., Kadowaki, T., Abe, N., Ratnayake, D. B., and Yamamoto, K. (1998) J. Biol. Chem. 273, 21225-21231[Abstract/Free Full Text]
  12. Kato, T., Takahashi, N., and Kuramitsu, H. K. (1992) J. Bacteriol. 174, 3889-3895[Abstract]
  13. Park, Y., and McBride, B. C. (1993) Infect. Immun. 61, 4139-4146[Abstract]
  14. Madden, T. E., Clark, V. L., and Kuramitsu, H. K. (1995) Infect. Immun. 63, 238-247[Abstract]
  15. Pavloff, N., Potempa, J., Pike, R. N., Prochazka, V., Kiefer, M. C., Travis, J., and Barr, P. J. (1995) J. Biol. Chem. 270, 1007-1010[Abstract/Free Full Text]
  16. Han, N., Whitlock, J., and Progulske-Fox, A. (1996) Infect. Immun. 64, 4000-4007[Abstract]
  17. Aduse-Opoku, J., Muir, J., Slaney, J. M., Rangarajan, M., and Curtis, M. A. (1997) J. Bacteriol. 179, 4778-4788[Abstract]
  18. Nakayama, K., Ratnayake, D. B., Tsukuba, T., Kadowaki, T., Yamamoto, K., and Fujimura, S. (1998) Mol. Microbiol. 27, 51-61[CrossRef][Medline] [Order article via Infotrieve]
  19. Curtis, M. A., Aduse-Opoku, J., Slaney, J. M., Rangarajan, M., Booth, V., Cridland, J., and Shepherd, P. (1996) Infect. Immun. 64, 2532-2539[Abstract]
  20. Booth, V., and Lehner, T. (1997) J. Periodontal. Res. 32, 54-60[Medline] [Order article via Infotrieve]
  21. Kelly, C. G., Booth, V., Kendal, H., Slaney, J. M., Curtis, M. A., and Lehner, T. (1997) Clin. Exp. Immunol. 110, 285-291[Medline] [Order article via Infotrieve]
  22. Shibata, Y., Hayakawa, M., Takiguchi, H., Shiroza, T., and Abiko, Y. (1999) J. Biol. Chem. 274, 5012-5020[Abstract/Free Full Text]
  23. Nakayama, K., Yoshimura, F., Kadowaki, T., and Yamamoto, K. (1996) J. Bacteriol. 178, 2818-2824[Abstract]
  24. Kadowaki, T., Nakayama, K., Yoshimura, F., Okamoto, K., Abe, N., and Yamamoto, K. (1998) J. Biol. Chem. 273, 29072-29076[Abstract/Free Full Text]
  25. Milner, P., Batten, J. E., and Curtis, M. A. (1996) FEMS Microbiol. Lett. 140, 125-130[CrossRef][Medline] [Order article via Infotrieve]
  26. Fletcher, H. M., Schenkein, H. A., Morgan, R. M., Bailey, K. A., Berry, C. R., and Macrina, F. L. (1995) Infect. Immun. 63, 1521-1528[Abstract]
  27. Okamoto, K., Misumi, Y., Kadowaki, T., Yoneda, M., Yamamoto, K., and Ikehara, Y. (1995) Arch. Biochem. Biophys. 316, 917-925[CrossRef][Medline] [Order article via Infotrieve]
  28. Feldhaus, M. J., Hwa, V., Cheng, Q., and Saylers, A. A. (1991) J. Bacteriol. 173, 4540-4543[Medline] [Order article via Infotrieve]
  29. Kishore, A. R., Kalfas, J. E. S., Forsgren, A., and Naidu, A. S. (1992) J. Med. Microbiol. 37, 341-345[Abstract]
  30. Gmur, R., Werner-Felmayer, G., and Guggenheim, B. (1988) Oral Microbiol. Immunol. 3, 181-186[Medline] [Order article via Infotrieve]
  31. Laemmli, U. K. (1970) Nature 227, 680-685[Medline] [Order article via Infotrieve]
  32. Fujimura, S., Shibata, Y., Hirai, K., and Nakamura, T. (1995) FEMS Immunol. Med. Microbiol. 10, 109-114[CrossRef][Medline] [Order article via Infotrieve]
  33. Amano, A., Kuboniwa, M., Kataoka, K., Tazaki, K., Inoshita, E., Nagata, H., Tamagawa, H., and Shizukuishi, S. (1995) FEMS Microbiol. Lett. 134, 63-67[CrossRef][Medline] [Order article via Infotrieve]
  34. Fujimura, S., Shibata, Y., Hirai, S., and Nakamura, T. (1996) Infect. Immun. 64, 2339-2342[Abstract]
  35. Watanabe-Kato, T., Hayashi, J., Terazawa, Y., Hoover, C. I., Nakayama, K., Hibi, E., Kawakami, N., Ikeda, T., Nakamura, H., Noguchi, T., and Yoshimura, F. (1998) Microb. Pathog. 24, 25-35[CrossRef][Medline] [Order article via Infotrieve]
  36. Pike, R., McGraw, W., Potempa, J., and Travis, J. (1994) J. Biol. Chem. 269, 406-411[Abstract/Free Full Text]
  37. Shah, H. N., and Williams, R. A. D. (1987) Curr. Microbiol. 15, 241-246
  38. Kuboniwa, M., Amano, A., and Shizukuishi, S. (1998) Biochem. Biophys. Res. Commun. 249, 38-43[CrossRef][Medline] [Order article via Infotrieve]
  39. Okuda, K., Slots, J., and Genco, R. J. (1981) Curr. Microbiol. 6, 7-12
  40. Slots, J., and Gibbons, R. J. (1978) Infect. Immun. 19, 254-264[Medline] [Order article via Infotrieve]
  41. Progulske-Fox, A., Tumwasorn, S., Lepine, G., Whitlock, J., Savett, D., Ferretti, J. J., and Banas, J. A. (1995) Oral Microbiol. Immunol. 10, 311-318[Medline] [Order article via Infotrieve]
  42. Isogai, H., Isogai, E., Yoshimura, F., Suzuki, T., Kagota, W., and Takano, K. (1988) Arch. Oral Biol. 33, 479-485[Medline] [Order article via Infotrieve]
  43. Yoshimura, F., Takahashi, K., Nadasaka, Y., and Suzuki, T. (1984) J. Bacteriol. 160, 949-957[Medline] [Order article via Infotrieve]
  44. Ogawa, T., and Hamada, S. (1994) Infect. Immun. 62, 3305-3310[Abstract]
  45. Lepine, G., and Progulske-Fox, A. (1996) Oral Microbiol. Immun. 11, 65-78[Medline] [Order article via Infotrieve]


Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.